| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Cost-effectiveness assessment of interferon alfa-2b as adjuvant therapy of high-risk resected cutaneous melanoma
|
Hillner, B.E
|
|
1998
|
34 |
S3 |
p. 18-21
4 p.
|
article
|
| 2 |
Future perspectives in specific immunotherapy of melanoma
|
Parmiani, G.
|
|
1998
|
34 |
S3 |
p. 42-47
6 p.
|
article
|
| 3 |
Incidence, risk factors and prevention of melanoma
|
MacKie, R.M
|
|
1998
|
34 |
S3 |
p. 3-6
4 p.
|
article
|
| 4 |
Introduction
|
Eggermont, A.M.M
|
|
1998
|
34 |
S3 |
p. 1-2
2 p.
|
article
|
| 5 |
New prognostic factors in melanoma: mRNA tumour markers
|
Keilholz, U
|
|
1998
|
34 |
S3 |
p. 37-41
5 p.
|
article
|
| 6 |
Role of lymphatic mapping and sentinel node biopsy in melanoma detection
|
Ross, M.I
|
|
1998
|
34 |
S3 |
p. 7-11
5 p.
|
article
|
| 7 |
Strategy of the EORTC-MCG trial programme for adjuvant treatment of moderate-risk and high-risk melanoma
|
Eggermont, A.M.M.
|
|
1998
|
34 |
S3 |
p. 22-26
5 p.
|
article
|
| 8 |
Systemic adjuvant treatment of high-risk melanoma: the role of interferon Alfa-2b and other immunotherapies
|
Kirkwood, J.M
|
|
1998
|
34 |
S3 |
p. 12-17
6 p.
|
article
|
| 9 |
The evidence for tamoxifen and chemotherapy as treatment for metastatic melanoma
|
Rusthoven, J.J
|
|
1998
|
34 |
S3 |
p. 31-36
6 p.
|
article
|
| 10 |
The treatment of metastatic uveal melanoma
|
Pyrhönen, S
|
|
1998
|
34 |
S3 |
p. 27-30
4 p.
|
article
|
Journal description